Barclays Maintains Overweight on Aptiv, Lowers Price Target to $77

Benzinga Newsdesk www.benzinga.com Negative 81.2%

Neg 81.2% Neu 0% Pos 0%

Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $105 to $77.

Comments

No comments yet. Be the first!